Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia - The role of prothymosin-α, inflammatory cytokines, and angiogenic factors
- PMID: 40672775
- PMCID: PMC12264595
- DOI: 10.1016/j.jcte.2025.100404
Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia - The role of prothymosin-α, inflammatory cytokines, and angiogenic factors
Abstract
Aim: This study investigates prothymosin-α (ProT-α), an immunomodulatory protein, as a potential biomarker for insulin resistance in gestational diabetes (GDM), and as a predictor of fetal growth by 20 weeks of gestation (wg). Methods: Forty-six women with singleton pregnancies were classified into GDM (n = 8) and normal glucose tolerance (NGT; n = 38) groups based on 75 g OGTT results. Maternal glucose, insulin, cytokines, and ProT-α levels were measured, and fetal growth was assessed by ultrasound at 20 wg, focusing on abdominal circumference (AC) and estimated fetal weight (EFW) percentiles. Results: Women with GDM were older, had a higher BMI, glucose, and insulin levels, with fetuses showing higher AC and EFW percentiles. IL-8, TNFα, and IL-1α were lower in the GDM group, while ProT-α was also lower but not significantly. ProT-α inversely correlated with EFW percentiles, independent of GDM. Regression analysis identified 2-hour post-load glucose, VEGF, and EGF as positive predictors of fetal growth acceleration, while IL-10 and ProT-α were negative predictors. Conclusions: Fetal growth is influenced by maternal glucose, inflammation, and angiogenesis. ProT-α may serve as an independent biomarker for predicting fetal growth in early pregnancy, suggesting further investigation into its role in GDM, obesity, and insulin resistance.
Keywords: Cytokines; Fetal growth; Insulin resistance; Pregnancy; Prothymosin-α.
© 2025 The Authors. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Different strategies for diagnosing gestational diabetes to improve maternal and infant health.Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD007122. doi: 10.1002/14651858.CD007122.pub4. Cochrane Database Syst Rev. 2017. PMID: 28832911 Free PMC article.
-
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.Health Technol Assess. 2010 Sep;14(45):1-183. doi: 10.3310/hta14450. Health Technol Assess. 2010. PMID: 20868615
-
Different intensities of glycaemic control for women with gestational diabetes mellitus.Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2023 Oct 10;10:CD011624. doi: 10.1002/14651858.CD011624.pub3. PMID: 27055233 Free PMC article. Updated.
-
Predictive value of fetal Doppler velocimetry, fetal growth trajectory and maternal serum biomarkers for short-term adverse perinatal outcome: secondary analysis of DRIGITAT study.Ultrasound Obstet Gynecol. 2025 Jul 11. doi: 10.1002/uog.29266. Online ahead of print. Ultrasound Obstet Gynecol. 2025. PMID: 40641303
-
Different strategies for diagnosing gestational diabetes to improve maternal and infant health.Cochrane Database Syst Rev. 2015 Jan 21;1:CD007122. doi: 10.1002/14651858.CD007122.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Aug 23;8:CD007122. doi: 10.1002/14651858.CD007122.pub4. PMID: 25604891 Updated.
References
-
- Hartling L., Dryden D.M., Guthrie A., Muise M., Vandermeer B., Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann. Intern. Med. 2013;159:123–129. - PubMed
-
- Chiefari E., Arcidiacono B., Foti D., Brunetti A. Gestational diabetes mellitus: an updated overview. J. Endocrinol. Invest. 2017;40:899–909. - PubMed
-
- Mirabelli M., Chiefari E., Tocci V., Greco E., Foti D., Brunetti A. Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. Curr. Opin. Pharmacol. 2021;60:1–10. - PubMed
LinkOut - more resources
Full Text Sources